Saturday, August 20, 2016

TAFLOTAN (TAFLUPROST 0.0015%) LAUNCH IN KOTA KINABALU 

Santen Pharmaceutical Ltd., Japan, launched their new prostaglandin analogue, Taflotan, in Kota Kinabalu, Malaysia on 20th August 2016. The launch was accompanied by a talk by Dr Hoh Sek Tien from Mount Novena & Gleneagles Hospital, Singapore. 



No comments:

Post a Comment

GLAUCOMA AS A CENTRAL NEURODEGENERATIVE DISEASE

    The major length of the axon of the retinal ganglion cells (RGC) is extra-ocular, with pre-chiasmal, chiasmal and post-chiasmal compon...